PROXY STATEMENT

Company

CERO THERAPEUTICS HOLDINGS, INC.

Filed

December 14, 2023

Period of Report

January 3, 2024

Accession Number

0001213900-23-095749

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →